NL7313519A - - Google Patents

Info

Publication number
NL7313519A
NL7313519A NL7313519A NL7313519A NL7313519A NL 7313519 A NL7313519 A NL 7313519A NL 7313519 A NL7313519 A NL 7313519A NL 7313519 A NL7313519 A NL 7313519A NL 7313519 A NL7313519 A NL 7313519A
Authority
NL
Netherlands
Application number
NL7313519A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7313519A publication Critical patent/NL7313519A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NL7313519A 1972-10-06 1973-10-02 NL7313519A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA153,515A CA985172A (en) 1972-10-06 1972-10-06 Compositions and methods for reducing blood cholesterol

Publications (1)

Publication Number Publication Date
NL7313519A true NL7313519A (cg-RX-API-DMAC10.html) 1974-04-09

Family

ID=4094630

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7313519A NL7313519A (cg-RX-API-DMAC10.html) 1972-10-06 1973-10-02

Country Status (16)

Country Link
US (1) US3890438A (cg-RX-API-DMAC10.html)
AU (1) AU477269B2 (cg-RX-API-DMAC10.html)
BE (1) BE805634A (cg-RX-API-DMAC10.html)
CA (1) CA985172A (cg-RX-API-DMAC10.html)
CS (1) CS197387B1 (cg-RX-API-DMAC10.html)
DD (1) DD106948A5 (cg-RX-API-DMAC10.html)
DE (1) DE2348176A1 (cg-RX-API-DMAC10.html)
ES (1) ES419355A1 (cg-RX-API-DMAC10.html)
FR (1) FR2201893B1 (cg-RX-API-DMAC10.html)
GB (1) GB1439625A (cg-RX-API-DMAC10.html)
HU (1) HU169814B (cg-RX-API-DMAC10.html)
IE (1) IE38274B1 (cg-RX-API-DMAC10.html)
IN (1) IN138921B (cg-RX-API-DMAC10.html)
NL (1) NL7313519A (cg-RX-API-DMAC10.html)
SE (1) SE403886B (cg-RX-API-DMAC10.html)
ZA (1) ZA737246B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838716A1 (de) * 1988-11-15 1990-05-17 Kanoldt Arzneimittel Gmbh Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
DE69933016T2 (de) * 1998-03-26 2007-03-29 Phytopharm Plc, Godmanchester Steroidale saponine zur behandlung der alzheimerischen krankheit
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US20030118673A1 (en) * 1998-03-26 2003-06-26 Zongqin Xia Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
GB2347676A (en) * 1999-03-08 2000-09-13 Phytopharm Plc Screening method
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
WO2003022287A1 (fr) * 2001-08-24 2003-03-20 Jilin Tianyao Science And Technology Co. Ltd. UTILISATION DE 3β-HYDROXY-5-SPIROSTENE POUR PREVENIR OU TRAITER DES MALADIES OU DES ETATS CARDIO-VASCULAIRES, INHIBER DES TUMEURS ET REDUIRE LES LIPIDES SANGUINS
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
WO2003086411A1 (fr) * 2002-04-15 2003-10-23 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Composes et techniques de preparation de carboxylate de diosgenine et d'un derive de succinate monoester de diosgenine
GB0409567D0 (en) 2004-04-28 2004-06-02 Phytopharm Plc Chemical compounds
US20090209489A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system
US20090209486A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions of carbohydrates as dietary supplements
US20090208588A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown GERD carbohydrate compositions
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
WO2012010896A1 (en) 2010-07-20 2012-01-26 Phytopharm Plc Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders
FR3133158A1 (fr) 2022-03-04 2023-09-08 Psa Automobiles Sa Procédé de gestion énergetique d’une prise d’alimentation d’accessoire dans un véhicule automobile à l’arrêt

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630211A (cg-RX-API-DMAC10.html) * 1962-03-28

Also Published As

Publication number Publication date
IN138921B (cg-RX-API-DMAC10.html) 1976-04-17
IE38274L (en) 1974-04-06
DE2348176A1 (de) 1974-04-11
ES419355A1 (es) 1976-03-01
FR2201893A1 (cg-RX-API-DMAC10.html) 1974-05-03
CA985172A (en) 1976-03-09
FR2201893B1 (cg-RX-API-DMAC10.html) 1977-09-09
BE805634A (fr) 1974-04-03
GB1439625A (en) 1976-06-16
US3890438A (en) 1975-06-17
SE403886B (sv) 1978-09-11
AU6110873A (en) 1975-04-10
IE38274B1 (en) 1978-02-01
CS197387B1 (en) 1980-05-30
DD106948A5 (cg-RX-API-DMAC10.html) 1974-07-12
HU169814B (cg-RX-API-DMAC10.html) 1977-02-28
AU477269B2 (en) 1976-10-21
ZA737246B (en) 1975-04-30

Similar Documents

Publication Publication Date Title
JPS523236B2 (cg-RX-API-DMAC10.html)
FR2201893B1 (cg-RX-API-DMAC10.html)
JPS55942B2 (cg-RX-API-DMAC10.html)
IN139182B (cg-RX-API-DMAC10.html)
JPS4894615A (cg-RX-API-DMAC10.html)
JPS5234369B2 (cg-RX-API-DMAC10.html)
JPS5128986B2 (cg-RX-API-DMAC10.html)
FR2187632B3 (cg-RX-API-DMAC10.html)
JPS5143794Y2 (cg-RX-API-DMAC10.html)
JPS5133216B2 (cg-RX-API-DMAC10.html)
JPS4966851U (cg-RX-API-DMAC10.html)
JPS48103932U (cg-RX-API-DMAC10.html)
JPS5030469Y2 (cg-RX-API-DMAC10.html)
JPS4828855Y1 (cg-RX-API-DMAC10.html)
JPS4956552U (cg-RX-API-DMAC10.html)
JPS4969360U (cg-RX-API-DMAC10.html)
CS151864B1 (cg-RX-API-DMAC10.html)
CS154550B1 (cg-RX-API-DMAC10.html)
CS155025B1 (cg-RX-API-DMAC10.html)
CS159430B1 (cg-RX-API-DMAC10.html)
CS160339B1 (cg-RX-API-DMAC10.html)
JPS4878728A (cg-RX-API-DMAC10.html)
JPS4879013A (cg-RX-API-DMAC10.html)
CH584708A5 (cg-RX-API-DMAC10.html)
CH598164A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed